¡Desconecta con la aplicación Player FM !
Helen Ayles and Musonda Simwinge on the PopART trial
Manage episode 346361510 series 2826339
Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.
Read the PopART trial papers:
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
73 episodios
Manage episode 346361510 series 2826339
Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.
Read the PopART trial papers:
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
73 episodios
Alle afleveringen
×Bienvenido a Player FM!
Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.